English  l  Korean

Microbiome Research

The cells of the human body are outnumbered ten times by the coexisting microbial numbers.

The microbiome represents the total genetic information of the microbial community as a whole, comprising bacteria, fungi, protozoa and viruses inhabiting the human ecological environment, and carries 200 times the number of genes compared to the human genome. The enormous microbiological diversity of the gut ecosystem is reflected by an estimated 1,500 bacterial species, with a wide range of physiological properties and metabolic pathways.

Research has shown that these microbes communicate with the host to maintain a healthy balance. Dysbiosis (“microbial imbalance or impaired microbiota”), is considered to be either the major cause or result of certain diseases such as obesity, diabetes, IBD/IBS, atopic dermatitis, acne, asthma, Alzheimer’s disease, etc. Our research aims at maintaining or restoring the “fitness” of our gastro-intestinal system.

Therefore, the major focus is on modulating the microbiome through the application of either carefully selected conventional probiotics and/or next generation probiotics in order to regain and maintain a healthy microbial balance.

Area of focus

  • Dermabiotics :

    - Skin Microbiome
  • Psychobiotics :

    - Gut-brain axis
  • Pulmobiotics :

    - Lung Microbiome
  • Gut Microbiome :

    - Metabolic Disease such as Obesity and Diabetes
    - Bowel Disorders Including Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS)
    - Etc.
  • Personalized Probiotics

  • Pharmabiotics :

    - Next Generation Probiotics